(RDEB) RELX - Ratings and Ratios
Cigarettes, Vapes, Pods, Tapes
Description: RDEB RELX
RELX PLC, listed on XETRA under the ticker symbol RDEB, is a UK-based company operating in the Specialty Chemicals sub-industry as classified by GICS. The companys financial performance and stock behavior are influenced by its exposure to various economic drivers, including global demand for specialty chemicals, which are used in a wide range of applications across industries such as pharmaceuticals, agriculture, and manufacturing.
To evaluate RELX PLCs financial health and potential for future growth, key performance indicators (KPIs) such as revenue growth rate, net profit margin, and return on equity (RoE) are crucial. The provided RoE of 110.69% suggests an exceptionally high return on equity, indicating that the company is generating significant profits from its shareholders equity. However, such a high RoE might also imply a relatively low equity base compared to its earnings or significant one-off gains. Further analysis is needed to understand the sustainability of this RoE.
The companys valuation, as reflected by its price-to-earnings (P/E) ratio of 36.87 and forward P/E of 30.12, indicates that investors are willing to pay a premium for RELX PLCs shares relative to its current and expected earnings. This could be due to the companys strong market position, growth prospects, or the markets confidence in its ability to maintain or improve its earnings. The difference between the current and forward P/E ratios suggests expected earnings growth, which could be driven by the companys strategic initiatives or favorable market conditions.
RELX PLCs market capitalization stands at approximately 80.36 billion EUR, categorizing it as a large-cap company. This size typically implies a certain level of stability and liquidity, making it easier for investors to buy and sell shares without significantly affecting the stock price. The companys beta of 0.475 indicates that its stock is less volatile than the overall market, suggesting a potentially defensive investment profile.
Key economic drivers for RELX PLC include global economic growth, demand for information and analytics (as RELX provides information and analytics to professional and business customers), and the overall health of the industries it serves. As a provider of information and analytics, the companys performance is closely tied to the spending patterns of its customers, which can be influenced by broader economic trends.
To further assess the investment potential of RELX PLC, a deeper dive into its financial statements, including income statement analysis (such as the yearly Income Tax Expense mentioned), cash flow statements, and balance sheet analysis, would be necessary. This would help in understanding the companys profitability, cash generation capabilities, and financial leverage, ultimately informing a more comprehensive investment thesis.
RDEB Stock Overview
Market Cap in USD | 88,580m |
Sub-Industry | Specialty Chemicals |
IPO / Inception |
RDEB Stock Ratings
Growth Rating | 65.2% |
Fundamental | 90.6% |
Dividend Rating | 46.3% |
Return 12m vs S&P 500 | -18.8% |
Analyst Rating | - |
RDEB Dividends
Dividend Yield 12m | 2.02% |
Yield on Cost 5y | 5.01% |
Annual Growth 5y | 5.60% |
Payout Consistency | 73.4% |
Payout Ratio | 60.9% |
RDEB Growth Ratios
Growth Correlation 3m | -87% |
Growth Correlation 12m | 33.1% |
Growth Correlation 5y | 96.9% |
CAGR 5y | 18.09% |
CAGR/Max DD 5y | 0.97 |
Sharpe Ratio 12m | -0.19 |
Alpha | -12.12 |
Beta | 0.312 |
Volatility | 21.43% |
Current Volume | 0.8k |
Average Volume 20d | 0.4k |
Stop Loss | 38.6 (-3%) |
Signal | 1.38 |
Piotroski VR‑10 (Strict, 0-10) 8.0
Net Income (3.71b TTM) > 0 and > 6% of Revenue (6% = 1.12b TTM) |
FCFTA 0.27 (>2.0%) and ΔFCFTA 9.70pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -14.64% (prev -17.08%; Δ 2.44pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.34 (>3.0%) and CFO 5.09b > Net Income 3.71b (YES >=105%, WARN >=100%) |
Net Debt (6.42b) to EBITDA (6.99b) ratio: 0.92 <= 3.0 (WARN <= 3.5) |
Current Ratio 0.52 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (1.88b) change vs 12m ago -2.44% (target <= -2.0% for YES) |
Gross Margin 63.46% (prev 60.61%; Δ 2.84pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 120.1% (prev 78.36%; Δ 41.76pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 9.16 (EBITDA TTM 6.99b / Interest Expense TTM 604.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.69
(A) -0.18 = (Total Current Assets 3.00b - Total Current Liabilities 5.72b) / Total Assets 15.13b |
(B) 0.14 = Retained Earnings (Balance) 2.08b / Total Assets 15.13b |
(C) 0.36 = EBIT TTM 5.53b / Avg Total Assets 15.48b |
(D) 0.02 = Book Value of Equity 272.0m / Total Liabilities 11.63b |
Total Rating: 1.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 90.56
1. Piotroski 8.0pt = 3.0 |
2. FCF Yield 5.74% = 2.87 |
3. FCF Margin 22.18% = 5.55 |
4. Debt/Equity 1.86 = 0.98 |
5. Debt/Ebitda 0.93 = 1.87 |
6. ROIC - WACC 35.69% = 12.50 |
7. RoE 110.7% = 2.50 |
8. Rev. Trend 95.25% = 4.76 |
9. Rev. CAGR 13.39% = 1.67 |
10. EPS Trend 94.76% = 2.37 |
11. EPS CAGR 29.50% = 2.50 |
What is the price of RDEB shares?
Over the past week, the price has changed by -3.91%, over one month by -11.28%, over three months by -15.73% and over the past year by -4.97%.
Is RELX a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RDEB is around 34.56 EUR . This means that RDEB is currently overvalued and has a potential downside of -13.17%.
Is RDEB a buy, sell or hold?
What are the forecasts/targets for the RDEB price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 37.9 | -4.8% |
RDEB Fundamental Data Overview
Market Cap GBP = 65.56b (76.05b EUR * 0.8621 EUR.GBP)
CCE Cash And Equivalents = 119.0m GBP (Cash And Short Term Investments, last quarter)
P/E Trailing = 34.6667
P/E Forward = 27.933
P/S = 7.9764
P/B = 30.3165
P/EG = 2.6588
Beta = 0.475
Revenue TTM = 18.59b GBP
EBIT TTM = 5.53b GBP
EBITDA TTM = 6.99b GBP
Long Term Debt = 5.07b GBP (from longTermDebt, last quarter)
Short Term Debt = 1.41b GBP (from shortTermDebt, last quarter)
Debt = 6.48b GBP (Calculated: Short Term 1.41b + Long Term 5.07b)
Net Debt = 6.42b GBP (from netDebt column, last quarter)
Enterprise Value = 71.92b GBP (65.56b + Debt 6.48b - CCE 119.0m)
Interest Coverage Ratio = 9.16 (Ebit TTM 5.53b / Interest Expense TTM 604.0m)
FCF Yield = 5.74% (FCF TTM 4.12b / Enterprise Value 71.92b)
FCF Margin = 22.18% (FCF TTM 4.12b / Revenue TTM 18.59b)
Net Margin = 19.98% (Net Income TTM 3.71b / Revenue TTM 18.59b)
Gross Margin = 63.46% ((Revenue TTM 18.59b - Cost of Revenue TTM 6.79b) / Revenue TTM)
Tobins Q-Ratio = 264.4 (set to none) (Enterprise Value 71.92b / Book Value Of Equity 272.0m)
Interest Expense / Debt = 2.28% (Interest Expense 148.0m / Debt 6.48b)
Taxrate = 23.97% (from yearly Income Tax Expense: 613.0m / 2.56b)
NOPAT = 4.20b (EBIT 5.53b * (1 - 23.97%))
Current Ratio = 0.52 (Total Current Assets 3.00b / Total Current Liabilities 5.72b)
Debt / Equity = 1.86 (Debt 6.48b / last Quarter total Stockholder Equity 3.48b)
Debt / EBITDA = 0.93 (Net Debt 6.42b / EBITDA 6.99b)
Debt / FCF = 1.57 (Debt 6.48b / FCF TTM 4.12b)
Total Stockholder Equity = 3.36b (last 4 quarters mean)
RoA = 24.55% (Net Income 3.71b, Total Assets 15.13b )
RoE = 110.7% (Net Income TTM 3.71b / Total Stockholder Equity 3.36b)
RoCE = 65.65% (Ebit 5.53b / (Equity 3.36b + L.T.Debt 5.07b))
RoIC = 42.36% (NOPAT 4.20b / Invested Capital 9.92b)
WACC = 6.67% (E(65.56b)/V(72.04b) * Re(7.16%)) + (D(6.48b)/V(72.04b) * Rd(2.28%) * (1-Tc(0.24)))
Shares Correlation 5-Years: -100.0 | Cagr: -0.79%
Discount Rate = 7.16% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈3.59b ; Y1≈4.42b ; Y5≈7.55b
Fair Price DCF = 70.24 (DCF Value 128.40b / Shares Outstanding 1.83b; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 95.25 | Revenue CAGR: 13.39%
Rev Growth-of-Growth: -11.97
EPS Correlation: 94.76 | EPS CAGR: 29.50%
EPS Growth-of-Growth: -13.84